Zonglin Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence.
Journal: Frontiers in pharmacology
Published: April 18, 2026
Intensive blood pressure reduction but an increased risk of peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials.
Journal: Annals of medicine
Published: December 13, 2025
Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional study.
Journal: Cardiovascular diabetology
Published: June 28, 2025
PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 11, 2025
Cardiovascular and brain effects of liraglutide in transthyretin amyloidosis (ATTR) mice models.
Journal: International journal of medical sciences
Published: February 16, 2025
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis of randomized controlled trials.
Journal: Expert review of clinical pharmacology
Published: January 31, 2025
The association between anti-inflammatory therapies and renal outcomes in patients with established cardiovascular disease or high cardiovascular risks: a meta-analysis of randomised controlled trials.
Journal: Inflammopharmacology
Published: November 28, 2024
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA.
Journal: Diabetes, obesity & metabolism
Published: August 19, 2024
Mulberry Twig Alkaloids Improved the Progression of Metabolic-Associated Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating the PGC1α/PPARα and KEAP1/NRF2 Pathways.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 17, 2024
Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials.
Journal: Alzheimer's research & therapy
Published: July 10, 2024
Last Updated: 09/26/2026